Evaluation of nanoparticle drug-delivery systems used in preclinical studies.

Sreeharsha, Nagaraja; Chitrapriya, Nataraj; Jang, Yoon Jung; Kenchappa, Vanaja

Sreeharsha, Nagaraja; Chitrapriya, Nataraj; Jang, Yoon Jung; Kenchappa, Vanaja.

Afiliação

Sreeharsha N; Department of Pharmaceutical Science, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Chitrapriya N; Department of Pharmaceutics, Vidya Siri College of Pharmacy, Bangalore 560035, India.
Jang YJ; Department of Chemistry, Yeungnam University Dae-dong, Gyeongsan City, Gyeong-buk 38541, Republic of Korea.
Kenchappa V; College of Basic Education, Yeungnam University Dae-dong, Gyeongsan City, Gyeong-bulk 38541, Republic of Korea.

Ther Deliv ; 12(4): 325-336, 2021 04.

Article em En | MEDLINE | ID: mdl-33759568

Assuntos

Sistemas de Liberação de Medicamentos; Nanopartículas; Animais; Portadores de Fármacos; Polímeros

Palavras-chave

EPR tumor targeting; active tumor targeting; biodistribution; dual drug delivery; in vivo performance; inorganic nanoparticles; polymeric nanoparticles; single drug delivery; stimuli-responsive drug release; synergistic activity; targeted ligand/receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Nanopartículas Limite: Animals Idioma: En Revista: Ther Deliv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google